United States · FDA National Drug Code directory
BLATTA ORIENTALIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0220-0865_0c0490ee-23f3-1cdb-e063-6394a90a8185
- Product NDC
- 0220-0865
- Form
- PELLET
- Composition / generic term
- BLATTA ORIENTALIS
- Labeler
- Boiron
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20240101
- Source listing expiry
- 20261231
Source-listed ingredients
- BLATTA ORIENTALIS — 200 [kp_C]/200[kp_C]
These values do not establish equivalence or a dose recommendation.
Packages
- 200 [kp_C] in 1 TUBE (0220-0865-41) · 0220-0865-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →